Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein's revenue has grown from roughly $3.1B in Q2 2024 to $3.5B in Q3 2026, with year-over-year growth between 4.0% and 7.7%, and gross margin holding within a narrow 28.7% to 31.8% band.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue grew steadily to $3.5B with gross margin of 29.8% to 31.8% in recent quarters, but operating margin of 5.4% to 6.5% suggests SG&A growth has absorbed much of the gross profit gains.
Henry Schein reported adjusted earnings per share of $1.32 and net sales of $3.37b, exceeding expectations and attracting investor interest.
The company's growth is driven by a new CEO, private-label expansion, and operational efficiency under KKR's restructuring.
Henry Schein is leveraging AI-driven software to enhance its business model and create new growth avenues.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 3, 2026 | $1.37+0.7% vs $1.36 | $3.5B-0.1% vs $3.5B |
Q3 2026 Aug 4, 2026 | $1.27+2.4% vs $1.24 | $3.5B+2.5% vs $3.4B |
Q2 2026 May 5, 2026 | $1.32+10.0% vs $1.20 | $3.4B+0.8% vs $3.3B |
Q1 2026 Feb 24, 2026 | $1.34+3.1% vs $1.30 | $3.4B+2.7% vs $3.3B |
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HSIC gears up for Q3 earnings with revenue growth expected across its three segments, fueled by dental products, specialty demand and cloud-based technology.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2026 financial results before the stock market opens on Tuesday, November 3, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer, R.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Benchmark HSIC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Henry Schein, Inc. (HSIC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $86.05 | $9.8B | 23.00 | 4.03% | 3.07% | 8.83% | — | |
| $140.68 | $2.18B | 23.38 | 11.89% | 4.45% | 18.55% | 0% | |
| $0.20 | $15.62M | -0.01 | -74.19% | -6.72% | — | — | |
| $1060.84 | $123.8B | 26.34 | 12.36% | 1.12% | — | 0.29% | |
| $271.72 | $63.64B | 34.82 | 14.23% | 0.71% | — | 0.76% | |
| $9.46 | $1.9B | -15.57 | -2.98% | -3.38% | -9.02% | 6.79% |
Henry Schein, Inc. (HSIC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Henry Schein, Inc. (HSIC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 3, 2026·SEC
Oct 8, 2026·SEC
Aug 4, 2026·SEC
Get notified when HSIC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Henry Schein, Inc. (HSIC) stock FAQ — growth, dividends, profitability & financials explained
Henry Schein, Inc. (HSIC) reported $13.73B in revenue over the trailing twelve months. Revenue was $13.18B in fiscal year 2025. That is 1488% more than the $830.0M of fiscal year 1996.
Henry Schein, Inc. (HSIC) grew revenue by 6.2% over the trailing twelve months, compared with the twelve months before.
Yes. Henry Schein, Inc. (HSIC) earned $421.0M in net income over the trailing twelve months (a 3.1% net margin).
Henry Schein, Inc. (HSIC) had a return on equity (ROE) of 8.8% over the trailing twelve months. That is below the market's typical 10-15%.
Henry Schein, Inc. (HSIC) generated $529.0M in free cash flow over the trailing twelve months.